Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
about
Vascular disease in systemic lupus erythematosusThrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assayObstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implicationsCatastrophic antiphospholipid syndrome: a clinical reviewNovel Phospholipid-Protein Conjugates Allow Improved Detection of Antibodies in Patients with Autoimmune DiseasesEffect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesisDiagnosis and management of catastrophic antiphospholipid syndrome.Antiphospholipid antibodies in iraqi women with recurrent mid-trimester abortionsCurrent treatment of antiphospholipid syndrome: lights and shadows.Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic EventsAntiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.The role of platelets in antiphospholipid syndrome.Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome.Recurrent pregnancy loss: current perspectivesAntiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers.Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.Presence of autoantibody against two placental proteins, peroxiredoxin 3 and peroxiredoxin 4, in sera of recurrent pregnancy loss patients.Activated protein C resistance and antiphospholipid antibodies in recurrent fetal loss: experience of a single referral center in northern iraqA polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus.A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1β production by human first trimester trophoblast.Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I.An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome.Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA CarriersThe complement system at the embryo implantation site: friend or foe?Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.Progesterone and autoimmune disease.Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome.Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome.ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in MiceEvaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndromeAnticoagulation in management of antiphospholipid antibody syndrome in pregnancy.Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.Thrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus.Detection of multiple annexin autoantibodies in a patient with recurrent miscarriages, fulminant stroke and seronegative antiphospholipid syndrome.
P2860
Q21285155-49095FB4-4CB1-4DB8-98E7-FA7E33068938Q26739950-18EE3D45-5F61-4678-9183-62E4E391C7EBQ26998188-CC896E1C-4FD3-4898-ACE9-EC145CE08514Q27009935-486C89C8-0F51-4E39-8DD7-9126F88601ADQ28552664-4E610503-E19F-4C03-8E6F-9CF5B2A447B6Q28740531-6DAD9158-CB40-4B3D-9418-B0FFDF015BC7Q30235356-14FD683A-E6F0-4227-9BF2-D19AA3B87200Q33406095-5C6BA23D-076B-4D09-857F-014354A4B7DBQ33423959-F797382B-D260-44E5-AC2E-E9FFF3C9FCFCQ33431396-679DD820-3AF0-41B6-BCBC-EB7FD1F60022Q33435408-13553B53-FA8C-4B3A-AC1A-1DFEBD29D467Q33439904-EEAE8BDF-2413-4D62-9AF4-12BF2A049C27Q33604935-47A13EE7-E7F2-43A4-8FB7-E5EA990761FCQ33713930-34221CD9-E863-43F7-A716-0C3AC4C58895Q33766670-BBF9A39E-8B6B-4F32-A124-486C79DC531EQ33948737-8609D343-2710-4E06-9B3F-F573B46EB9E9Q34287356-79B2DCBA-F880-4B88-BAE7-9B72D0B72635Q34476952-EF658E0C-D57C-401E-8E5F-EDD9B6B0875EQ34494348-B2EE1C64-5DAD-43C9-B390-9043D82FD628Q34569019-D4EB9C51-7A8A-4559-BC51-855A135DC5AAQ34722499-5737F2AB-2782-40CE-BC5D-E1DCC4EC4DF1Q34769721-8014E1EB-A3F1-4F4B-9957-BE133F8A9AEDQ35070716-11F978C3-18E1-461F-8C6F-52E1E8BD416CQ35124252-14B821DE-D0AF-4414-81BA-D70BB7FD23DDQ35152055-858F8474-B6ED-4B6B-B7C2-7DEF904B59E6Q35419865-807B0B29-4595-4908-B39F-3868F2CFAF03Q35621012-8BAA43EF-886C-47CA-9C96-83963780903BQ35854768-85AE7B4E-D9D4-4B38-B8F1-B3BB8522AC37Q35907083-7E9AEC26-20E5-4A47-9B02-14963AD624E4Q35927443-9AFE97FE-216F-4FF1-B21B-5E13A6689F59Q36087118-7247F533-BE8A-4C9A-B8A0-186E1DC8A8EAQ36202227-B4B9898B-1460-4B9E-90F1-CC30F699AAFFQ36299310-EAD8674E-DEBE-4E0C-9DA8-A2798C126DB3Q36472439-72737F91-2A47-4FD6-A558-B6468E9A0D5CQ36619367-FB71E7FD-2349-4BE9-A903-5A07C1C2D786Q36774243-4AD2A7DC-3703-4CE7-B851-5C9EB9303E00Q36879113-1D93A0CC-71F4-4BDF-94EC-E7DD59C4C560Q36923241-73279A45-E784-46B7-A6A9-E2D32A76BCD5Q36981341-D6AE7301-DE2A-4D53-B9CB-AE3F40ADCF11Q37011051-0B079BD9-E7CB-45BF-B700-0B6A3B658F4B
P2860
Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
@en
Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
@nl
type
label
Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
@en
Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
@nl
prefLabel
Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
@en
Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
@nl
P2093
P2860
P356
P1476
Pathogenesis of antiphospholipid syndrome: understanding the antibodies.
@en
P2093
Elena Raschi
Francesco Tedesco
M Orietta Borghi
P2860
P2888
P304
P356
10.1038/NRRHEUM.2011.52
P407
P577
2011-05-10T00:00:00Z
P5875
P6179
1049967834